AI-generated analysis. Always verify with the original filing.
Sagimet Biosciences Inc. furnished Item 2.02 results of operations, Item 7.01 investor presentation, and Exhibits 99.1 press release and 99.2 investor presentation dated March 11, 2026. Item 2.02 and Item 7.01 are not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.
Event Type
Disclosure
Mandatory
Variant
8-K
(including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “
of this Current Report on Form 8-K, including the information set forth in Exhibit 99.2, is being furnished and shall not be deemed “filed” for purposes of Sect
Financial Statements and Exhibits (d) Exhibits Exhibit No. Document 99.1 Press Release of Sagimet Biosciences Inc., dated March 11, 2026 99.2 Investor Presentat